Skip to content
AwardedBelgiumGoods

Spécialités pharmaceutiques à base d'everolimus 5mg et 10mg (voie orale).

Published
Published 2 December 2024
Deadline
Closed 21 January 2025

Overview

Spécialités pharmaceutiques à base d'everolimus 5mg et 10mg (voie orale).

Key details

Country
Belgium
Status
Awarded
Category
Goods
Procedure
Open
Published
2 December 2024
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€209,276
Award date
15 April 2025
Contract period
— → 25 March 2029
Winner
  • NOVARTIS PHARMA NV

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    2 May 2025

  2. Contract Notice

    2 December 2024

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Spécialités pharmaceutiques à base d'everolimus 5mg et 10mg (voie orale). — won by NOVARTIS PHARMA NV — Skim